| Dr Susan Conger, MD | |
|
11365 Dorsett Rd, Maryland Heights, MO 63043-3411 | |
| (314) 872-6400 | |
| (314) 872-6500 |
| Full Name | Dr Susan Conger |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 11365 Dorsett Rd, Maryland Heights, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134195654 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 101125 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Susan Conger, MD 11365 Dorsett Rd, Maryland Heights, MO 63043-3411 Ph: (314) 872-6400 | Dr Susan Conger, MD 11365 Dorsett Rd, Maryland Heights, MO 63043-3411 Ph: (314) 872-6400 |
News Archive
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
Argos Therapeutics today announced the presentation of data from the Phase 2a trial of AGS-004, demonstrating that the personalized immunotherapy has a positive impact on the genetic diversity of residual HIV virus, and also results in substantially increased time to viral rebound in HIV patients treated with AGS-004 following antiretroviral therapy (ART) interruption.
HealthSpring, Inc. announced today that it has priced its underwritten public offering of 7,500,000 shares of its common stock. The shares were resold by the underwriters at a price of $35.95 per share. The Company has also granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock.
POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that the United States District Court for the Eastern District of Texas has issued a favorable verdict in the litigation between POZEN and several generic pharmaceutical companies which had filed Abbreviated New Drug Applications (ANDAs) seeking approval from the U.S. Food and Drug Administration (FDA) to market generic copies of Treximet.
› Verified 4 days ago
Rosa M Suarez-solar, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11365 Dorsett Rd, Maryland Heights, MO 63043 Phone: 314-872-6400 Fax: 314-872-6500 | |
Dr. Brian J. Kelly, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11365 Dorsett Rd., Maryland Heights, MO 63043 Phone: 314-872-6430 Fax: 314-872-6500 | |
Connie D Simmons, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11365 Dorsett Rd., Maryland Heights, MO 63043 Phone: 314-872-6430 Fax: 314-872-6500 | |
Elizabeth Sugarbaker, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11365 Dorsett Rd, Maryland Heights, MO 63043 Phone: 314-872-6400 Fax: 314-872-6500 | |
Paul F Grim Iii, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11365 Dorsett Rd, Attention - Medical Staff Office, Maryland Heights, MO 63043 Phone: 314-872-6430 | |
Karen E Ruecker, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11365 Dorsett Road, Maryland Heights, MO 63043 Phone: 314-872-6400 Fax: 314-872-6500 |